| ABBRE-VIATION
|
Vaccine
Manufacturer/Distributor |
| ACM |
Acambis
Plc |
| ADL |
Adams
Laboratories |
| AGEN |
Antigenics,
Inc. |
| ALI |
Abbott
Laboratories, Inc. |
| ALKA |
ALK-Abelló |
| ALPV |
AlphaVax,
Inc. |
| ALT |
Alpha
Therapeutic Corporation |
| AML |
Amrad
Corporation |
| ANX |
Antex
Biologics, Inc. |
| APM |
Aventis
Pasteur MSD [joint venture of Aventis Pasteur and
Merck; successor entity for Pasteur-Mérieux MSD] |
| ARC |
American
Red Cross |
| ARM |
Armour
Pharmaceuticals [abbreviation and/or name superseded;
see CEN and AVB] |
| AVAN |
Avant
Immunotherapeutics, Inc. |
| AVB |
Aventis
Behring L.L.C. [successor entity for Armour Pharmaceuticals
(ARM) and Centeon L.L.C. (CTN)] |
| AVIR |
Aviron
[purchased by and absorbed into Medimmune (MEDI)] |
| AVP |
Aventis
Pasteur [includes Aventis Pasteur, S.A. (France),
Aventis Pasteur,
Inc. (Swiftwater, PA, USA),
Aventis Pasteur, Ltd. (Ontario, Canada)] [subsidiary
of Aventis S.A., successor
entity for Hoechst and Rhône-Poulenc, which absorbed Connaught
Laboratories, Inc. (CON), Connaught Laboratories, Ltd.
(CNL), Institut Mérieux (MER), Pasteur
Vaccins (PV), Pasteur Mérieux Sérums et
Vaccins (PMSV), Pasteur Mérieux Connaught (PMC),
Marion Merrell Dow, National Drug Company, Merrell National
Laboratories (MRN), and Richardson Merrell] |
| AVXT |
AVAX
Technologies, Inc. |
| ALX |
AltaRex
Corp. |
| BAY |
Bayer
AG [successor entity for Miles Laboratories, Inc.
(MIL) and Cutter Laboratories (CUT)] |
| BAVA |
Bavarian
Nordic GmbH |
| BAX |
Baxter
BioScience, Vaccines divison, Baxter
International Inc. [formerly Hyland Immuno division;
absorbed Immuno AG and Immuno International AG (IAG),
Immuno-U.S., Inc. (IUS), and North American Vaccine,
Inc. (NAV)] |
| BCH |
BioChem
Pharma [absorbed by merger into Shire
Biologics, a subsidiary of Shire Pharmaceuticals Group,
plc (SHP)] |
| BER |
Berna
Products Corporation [successor entity for Swiss Serum
and Vaccine Institute, Berne, Switzerland (SSV)] |
| BIB |
Bharat
Immunological and Biologicals Corp., Limited (India) |
| BIK |
BIKEN,
The Research Foundation for Microbial Diseases of
Osaka University [manufacturing collaboration with
Eisai Co., Ltd
(EISA)] |
| BIOF |
PT
Bio Farma (Indonesia) |
| BION |
Bionetics
Research, Inc. [inactive] [abbreviation and/or name superseded,
see OTC] |
| BIOR |
BioReliance
Corporation |
| BMAN |
Bio-Manguinhos
- Instituto de Tecnologia em
Imunobiológicos (Brazil) |
| BMY |
Bristol-Myers
Squibb |
| BPT |
BioPort
Corporation [successor entity for Michigan Biologic
Products Institute (MIP)] |
| CANS |
Cancer
Association of South Africa (CANSA) |
| CANT |
Cantacuzino
Institute |
| CDC |
Centers
for Disease Control and Prevention |
| CELS |
CEL-SCI
Corporation |
| CHIR |
Chiron
Corporation [includes wholly-owned subsidiaries PowderJect
Pharmaceuticals plc (PJP), Chiron
Behring GmbH & Co. which absorbed Behringwerke AG vaccine
business, Chiron S.p.A. which absorbed Sclavo (SCL) vaccine
business, and former Biocine joint venture of Chiron and Ciba
Geigy] |
| CHJD |
CheilJedang
Corporation (South Korea) |
| CNL |
Connaught
Laboratories, Ltd. (Ontario, Canada) [abbreviation and/or
name superseded; see AVP] |
| CNTB |
Cantab
Pharmaceuticals plc |
| COLY |
Coley
Pharmaceuticals Group |
| CON |
Connaught
Laboratories, Inc. (Swiftwater, PA, USA) [abbreviation
and/or name superseded; see AVP] (former subsidiary
of Connaught Laboratories, Ltd., Toronto, Ontario, Canada; prior
to privatisation: the Connaught Medical Research Laboratories
of the University of Toronto) |
| CRXA |
Corixa
Corporation |
| CSL |
CSL
Limited [formerly Commonwealth Serum Laboratories
Pty Ltd] |
| CTC |
Centocor
[wholly owned subsidiary of Johnson
& Johnson] |
| CTI |
Cancer
Therapeutics, Inc. |
| CTN |
Centeon
L.L.C. [successor entity for Armour Pharmaceutical Company
(ARM); abbreviation and/or name superseded, see AVB] |
| CUT |
Cutter
Laboratories [inactive] [see BAY] |
| CYTN |
Cytos
Biotechnology AG |
| DOW |
Dow Chemical
Company [inactive] |
| DVC |
DynPort
Vaccine Company LLC |
| EISA |
Eisai
Co., Ltd [manufacturing collaboration with Biken
(BIK)] |
| ELN |
Elan
Pharmaceuticals |
| EVN |
Evans
Vaccines Ltd. (wholly owned subsidiary of PowderJect
Pharmaceuticals Plc) [formerly Evans Medical, Ltd., which
acquired vaccine business of Wellcome (WEL); Evans was
acquired by and renamed to Medeva (MDV); MDV vaccine
business subsequently acquired by PowderJect and Evans name
restored] |
| FFF |
FFF
Enterprises |
| GPO |
Government
Pharmaceutical Organization (Thailand) |
| GSK |
GlaxoSmithKline
plc [merger of Glaxo Wellcome plc (GLX, which
absorbed Wellcome (WEL)) and SmithKline Beecham plc (SBB
and SB), which earlier absorbed Recherche et Industrie Thérapeutiques
(RIT)] |
| GRE |
Greer
Laboratories |
| HUM |
HUMAN
Serum Production and Medicine Manufacturing Company Limited
(Hungary) |
| IAF |
INRS-Institut
Armand-Frappier, Institut National de la Recherche Scientifique,
Université du Québec |
| IAG |
Immuno
AG,
Immuno International AG [abbreviation and/or name superseded,
absorbed into Baxter Healthcare Corporation (BAX)] |
| IDBE |
ID
Biomedical Corporation |
| IDT |
Impfstoffwerk
Dessau-Tornau GmbH (Germany) |
| IEX |
Inex
Pharmaceuticals Corporation |
| IIZ |
Institute
of Immunology (Zagreb, Croatia) |
| IMER |
Institut
Mérieux [inactive; formed Pasteur Vaccins (PV)
joint venture with Institut
Pasteur; later became Pasteur Mérieux Sérums
et Vaccins (PMSV), then Pasteur Mérieux Connaught
(PMC) subsidiary of Rhône-Poulenc, then Aventis Pasteur
(AVP)] |
| IMNR |
Immune
Response Corporation |
| INNX |
Innogenetics |
| INTC |
Intercell
AG, CISTEM Biotechnologies GmbH |
| INTV |
InterVax
Biologicals Limited |
| IOM |
Iomai
Corporation |
| IPVE |
Institute
of Poliomyelitis and Viral Encephalitis (Russia) |
| ITLV |
Intellivax,
Inc., Intellivax International,
Inc. [became wholly owned subsidiary of ID Biomedical Corporation
(IDBE)] |
| IUS |
Immuno-U.S.,
Inc. [abbreviation and/or name superseded, see BAX] |
| KGCC |
Korea
Green Cross Corporation (South Korea) |
| LED |
Lederle
Laboratories Division American Cyanamid Company [absorbed into
Wyeth (WYE)] |
| LET |
Laboratorios
Leti (Grupo Farmacéutico Leti) (Spain) |
| LG |
Lucky
Goldstar Chemical, Ltd. (Pharmaceutical
Division) (South Korea) |
| LIL |
Eli Lilly
and Company [inactive] |
| MAB |
Massachusetts
Biologic Laboratories, University of Massachusetts
[formerly Massachusetts
Public Health Biologic Laboratories] |
| MDG |
MediGene
AG |
| MDV |
Medeva
plc and Celltech
Medeva Pharma [inactive] [successor entity for vaccine line
of Evans Medical, Ltd. (EVN); line subsequently sold;
abbreviation and name superseded, see EVN] |
| MEDI |
MedImmune,
Inc. [purchased Aviron (AVIR)] |
| MEJ |
Mead
Johnson [inactive] [subsidiary of Bristol-Myers Squibb BMY] |
| MICR |
Microscience
Ltd |
| MIL |
Miles
Laboratories [abbreviation and/or name superseded; see
BAY] |
| MIP |
Michigan
Biologic Products Institute (formerly Michigan Department
of Public Health) [abbreviation and/or name superseded; see
BP] |
| MRK |
Merck
and Co., Inc. [successor name for Merck, Sharpe, and
Dohme, Inc. (MSD)] |
| MRN |
Merrell
National Laboratories, Division of Richardson Merrell
[inactive, see AVP] |
| MSD |
Merck,
Sharpe, and Dohme, Inc. [abbreviation and/or name superseded;
see MRK] |
| NABI |
NABI
[successor entity for North American Biologicals, Inc.] |
| NAV |
North
American Vaccine, Inc. [absorbed into Baxter Healthcare
Corporation (BAX)] |
| NCI |
National
Cancer Institute, National Institutes of Health (USA) |
| NCIP |
National
Center of Infectious and Parasitic Diseases (Sofia, Bulgaria) |
| NOV |
Novartis
[formerly Sandoz (SAN) and Ciba-Geigy] |
| NVI |
Nederlands
Vaccin Instituut (Netherlands Vaccine Institute) [see
RIVM and SVM] |
| NWBT |
Northwest
Biotherapeutics, Inc. |
| NYB |
New
York Blood Center |
| ORA |
OraVax,
Inc. [abbreviation and/or name superseded: subsidiary
of Peptide Therapeutics Group, plc; see PTE] |
| ORT |
Ortho-Clinical
Diagnostics [a Johnson & Johnson company; successor
entity for Ortho Diagnostic Systems, Inc.] |
| OTC |
Organon
Teknika Corporation, Organon
Teknika, B.V. [successor entity for Bionetics Research,
Inc. (BIR)] |
| PD |
Parke
Davis [inactive, traqnsferred influenza vaccine production
to Parkedale Pharmaceuticals (PDL)] |
| PDL |
Parkedale
Pharmaceuticals, Inc. (subsidiary of
King Pharmaceuticals, Inc.) [inactive; successor entity
for Parke Davis influenza vaccine production] |
| PFI |
Pfizer,
Ltd. [inactive] |
| PHMX |
Pharmexa
A/S |
| PHR |
Philips
Roxane, Inc. [inactive name; became Solvay Pharmaceuticals (SOL)] |
| PJP |
PowderJect
Pharmaceuticals plc [wholly owned subsidiary of Chiron
Corporation (CHIR). Includes PowderJect Vaccines,
Inc.; PowderJect earlier acquired SBL Vaccin AB (SBL)
and the vaccine business of Medeva (MDV), restoring the
Evans name to the wholly-owned subsidiary, Evans Vaccines, Ltd.
(see EVN)] |
| PMC |
Pasteur
Mérieux Connaught [abbreviation and name superseded;
see AVP] |
| PMSV |
Pasteur
Mérieux Sérums et Vaccins [formerly Pasteur Vaccines
(PV) joint venture of Institut
Pasteur and Institut Mérieux (IMER); became Pasteur
Mérieux Connaught (PMC) subsidiary of Rhône-Poulenc,
then Aventis Pasteur (AVP)] |
| PRFB |
Groupe
Pierre Fabre: Centre d'Immunologie
Pierre Fabre |
| PRX |
Praxis
Biologics [absorbed into Wyeth (WYE)] |
| PTE |
Peptide
Therapeutics Group, plc |
| PTM |
Pitman-Moore,
Inc., Pitman-Moore Pharmaceuticals, Ltd. [inactive; absorbed
into International Minerals and Chemical Corporation] |
| PV |
Pasteur
Vaccins [inactive; joint venture of Institut
Pasteur and Institut Mérieux (IMER); later became
Pasteur Mérieux Sérums et Vaccins (PMSV),
then Pasteur Mérieux Connaught (PMC) subsidiary
of Rhône-Poulenc, then Aventis Pasteur (AVP)] |
| QUA |
Quad Pharmaceuticals,
Inc. [inactive] [absorbed into Par
Pharmaceuticals, Inc., Pharmaceutical Resources, Inc.] |
| RIT |
Recherche
et Industrie Thérapeutiques [inactive; antecedent company
of GlaxoSmithKline (GSK)] |
| RIVM |
Rijksinstituut
voor Volksgezondheid en Milieu [National Institute
of Public Health and the Environment] (as of 2003, vaccine activities
reorganized into the Stichting
ter bevordering van de Volksgezondheid en Milieuhygiëne
(SVM) [Foundation for the Promotion of
Public Health and Environmental Hygiene] and the Netherlands
Vaccine Institute (NVI) |
| SAN |
Sandoz
[inactive, see Novartis (NOV)] |
| SBB |
SmithKline
Beecham Biologicals [component of former SmithKline Beecham
Pharmaceuticals (SB); merged into GlaxoSmithKline; see GSK] |
| SBL |
SBL
Vaccin AB (Sweden) [absorbed into PowderJect Pharmaceuticals
plc (PJP)] |
| SCHR |
Schering
AG (Germany) |
| SCL |
Sclavo,
S.p.A [vaccine business absorbed into former Biocine joint
venture of Chiron and Ciba-Geigy, and later into Chiron Corporation
(CHIR)] |
| SGP |
Schering-Plough
Corporation (USA) |
| SHP |
Shire
Biologics, a wholly-owned subsidiary of Shire
Pharmaceuticals Group plc [absorbed BioChem Pharma
(BCH) through merger] |
| SII |
Serum
Institute of India, Ltd. |
| SKB |
SmithKline
Beecham [abbreviation and/or name superseded; see
SBB] |
| SOL |
Solvay
Pharmaceuticals [influenza
product] [successor company to Philips Roxane, Inc. (PHR)] |
| SSB |
StressGen
Biotechnologies Corporation |
| SSI |
Statens
Serum Institut (Denmark) |
| SSV |
Swiss
Serum and Vaccine Institute (Berne, Switzerland) [abbreviation
and/or name superseded; see BER] |
| SVM |
Stichting
ter bevordering van de Volksgezondheid en Milieuhygiëne
(Foundation for the Promotion of Public Health and Environmental
Hygiene, the Netherlands; see RIVM and NVI]
|
| TDH |
Texas
Department of Health Resources [inactive] |
| TOR |
Torlak
Immunology and Virology Institute (Serbia) |
| TRGN |
Transgene
S.A. |
| TSI-GSD |
The Salk
Institute - Government Services Division [inactive; formerly
a division of The Salk Institute
for Biological Studies; absorbed into Aventis Pasteur, Inc.
(AVP)] |
| UIL |
University
of Illinois [inactive] |
| ULEI |
Universiteit
Leiden |
| UQU |
University
of Queensland |
| USA |
United
States Army Medical Research and Materiel Command |
| VHL |
Virax
Holdings Limited |
| VXGN |
VaxGen,
Inc. |
| WA |
Wyeth-Ayerst
[abbreviation/name superseded; see WYE] |
| WAL |
Wyeth-Ayerst
Laboratories [abbreviation/name superseded; see WYE] |
| WEL |
Wellcome;
Burroughs Wellcome; Wellcome plc [inactive] [merged into
Glaxo Wellcome, but its vaccine business acquired by Evans Medical,
Ltd. (EVN)] |
| WIS |
The
Wistar Institute (University of Pennsylvania) |
| WLV |
Wyeth-Lederle
Vaccines (and Pediatrics) [abbreviation/name superseded;
see WYE] |
| WYE |
Wyeth
Pharmaceuticals, division of Wyeth
[renamed from American Home Products, encompassing former Wyeth-Ayerst
Laboratories (WAL); Wyeth-Ayerst (WA), Wyeth-Lederle
Vaccines (and Pediatrics) (WLV), Wyeth Laboratories,
Inc. (WYL), Lederle Laboratories Division American Cyanamid
Company (LED), and Praxis Biologics (PRX)] |
| WYL |
Wyeth
Laboratories, Inc. [abbreviation/name superseded; see
WYE] |